Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates

Current Epidemiology and Growing Resistance of Gram-Negative Pathogens

(2012) David M. Livermore   KOREAN JOURNAL OF INTERNAL MEDICINE

Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii

(2011) Young Kyoung Park et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

(2011) Kyong Ran Peck et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In Vitro Antimicrobial Activity and Mutant Prevention Concentration of Colistin against Acinetobacter baumannii

(2010) Y. Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutant Prevention Concentrations of Four Carbapenems against Gram-Negative Rods

(2010) K. Credito et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

(2010) J. H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System

(2009) M. D. Adams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach

(2009) Joseph M. Blondeau   VETERINARY DERMATOLOGY